Sign in

CIK 0001738021 · Non-accelerated filer<br>Smaller reporting company

Compass Therapeutics, Inc.

Sign in to watch
Ticker
CMPX
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
operating
Phone
617-500-8099
Business address
80 GUEST STREET, BOSTON, MA, 02135
Former names
Olivia Ventures, Inc.
  1. 4 Open-market buy Director bought 402,000 shares at $3.21 ($1,290,420)
  2. 4 Open-market buy Director bought 402,000 shares at $3.21 ($1,290,420)
  3. SC 13D/A Stake Beneficial Ownership Report
  4. 10-Q Report Quarterly Report
  5. 8-K Event Material agreement · Unregistered share sale · Executive or director change
  6. 4 Open-market buy CHIEF EXECUTIVE OFFICER bought 10,000 shares at $2.32 ($23,200)
  7. 4 Open-market buy CHIEF EXECUTIVE OFFICER bought 15,000 shares at $2.27 ($34,050)
  8. 4 Open-market buy CHIEF EXECUTIVE OFFICER bought 15,000 shares at $3.03 ($45,450)
  9. 4 Open-market buy CHIEF EXECUTIVE OFFICER bought 15,000 shares at $2.83 ($42,450)
  10. 8-K Event Executive or director change
  11. 4 Open-market buy CHIEF EXECUTIVE OFFICER bought 15,000 shares at $3.05 ($45,750)
  12. 4 Open-market buy CHIEF EXECUTIVE OFFICER bought 15,000 shares at $2.64 ($39,600)
  13. 4 Open-market buy CHIEF EXECUTIVE OFFICER bought 15,000 shares at $2.58 ($38,700)
  14. 424B5 Offering Prospectus
  15. 8-K Event Material agreement · Agreement ended
  16. 10-Q Report Quarterly Report
  17. 4 Open-market buy CHIEF EXECUTIVE OFFICER bought 20,000 shares at $2.80 ($56,000)
  18. 4 Open-market buy CHIEF EXECUTIVE OFFICER bought 20,000 shares at $2.34 ($46,800)
  19. 4 Open-market buy CHIEF EXECUTIVE OFFICER bought 30,000 shares at $2.29 ($68,700)
  20. 4 Open-market buy CHIEF EXECUTIVE OFFICER bought 30,000 shares at $2.83 ($84,900)

Page 11 of 19 · 362 filings